Monique Dontenwill Selected Research

Neoplasms (Cancer)

6/2023	Triphenylphosphonium-functionalized N-heterocyclic carbene platinum complexes [(NHC-TPP+)Pt] induce cell death of human glioblastoma cancer stem cells.
5/2023	Glioblastoma Metabolism: Insights and Therapeutic Strategies.
2/2023	Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications.
1/2023	Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction.
8/2021	Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma.
6/2021	Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma.
4/2021	A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials.
3/2021	Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells.
1/2021	Biological Relevance of RGD-Integrin Subtype-Specific Ligands in Cancer.
4/2020	Hypoxia Inducible Factors' Signaling in Pediatric High-Grade Gliomas: Role, Modelization and Innovative Targeted Approaches.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monique Dontenwill Research Topics

Disease

31	Neoplasms (Cancer) 06/2023 - 06/2006
18	Glioblastoma (Glioblastoma Multiforme) 06/2023 - 01/2009
15	Glioma (Gliomas) 05/2023 - 02/2009
8	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2009
4	Squamous Cell Carcinoma of Head and Neck 07/2023 - 12/2015
3	Hypoxia (Hypoxemia) 03/2022 - 01/2020
3	Astrocytoma (Pilocytic Astrocytoma) 05/2008 - 10/2005
2	Osteosarcoma (Osteogenic Sarcoma) 03/2022 - 01/2020
2	Bone Neoplasms (Bone Cancer) 03/2022 - 01/2020
2	Carcinoma (Carcinomatosis) 08/2013 - 09/2010
1	Carcinogenesis 07/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023
1	Necrosis 01/2020
1	Basal Cell Carcinoma (Rodent Ulcer) 11/2018
1	Neoplasm Metastasis (Metastasis) 12/2015
1	Colonic Neoplasms (Colon Cancer) 08/2013
1	Starvation 12/2003

Drug/Important Bio-Agent (IBA)

22	IntegrinsIBA 09/2022 - 06/2006
8	Biomarkers (Surrogate Marker)IBA 07/2023 - 12/2015
5	Integrin alpha5beta1IBA 03/2021 - 06/2006
4	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 09/2010
4	Small Interfering RNA (siRNA)IBA 05/2014 - 09/2010
3	Fibronectins (Fibronectin)IBA 12/2021 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 08/2021 - 08/2013
3	Caveolin 1IBA 06/2021 - 02/2009
2	carbeneIBA 06/2023 - 10/2022
2	PlatinumIBA 06/2023 - 10/2022
2	Cetuximab (Erbitux)FDA Link 01/2023 - 06/2021
2	LigandsIBA 01/2023 - 01/2021
2	Nucleic AcidsIBA 09/2022 - 06/2017
2	Cell Surface ReceptorsIBA 09/2022 - 09/2019
2	Peptides (Polypeptides)IBA 01/2021 - 06/2016
2	Membrane Proteins (Integral Membrane Proteins)IBA 09/2019 - 06/2017
2	Phosphotransferases (Kinase)IBA 05/2019 - 10/2005
2	Antineoplastic Agents (Antineoplastics)IBA 06/2016 - 01/2009
2	ellipticineIBA 09/2010 - 01/2009
2	SJ749IBA 02/2009 - 06/2006
1	MicroRNAs (MicroRNA)IBA 07/2023
1	triphenylphosphoniumIBA 06/2023
1	EpiregulinIBA 01/2023
1	IronIBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	PolymersIBA 12/2022
1	PolyethyleneimineIBA 10/2022
1	Drug CarriersIBA 10/2022
1	2-toluenesulfonamide (OTS)IBA 03/2022
1	SolventsIBA 06/2021
1	A-Form DNA (A-DNA)IBA 05/2021
1	Tyrosine Kinase InhibitorsIBA 03/2021
1	Integrin alpha5IBA 03/2021
1	Gefitinib (Iressa)FDA Link 03/2021
1	PeptidomimeticsIBA 01/2021
1	Oxygen (Dioxygen)IBA 04/2020
1	RNA (Ribonucleic Acid)IBA 11/2019
1	Histones (Histone)IBA 11/2019
1	Nucleotide AptamersIBA 09/2019
1	Growth Factor ReceptorsIBA 05/2019
1	adhesion receptorIBA 05/2019
1	tyrosine receptor (receptor, tyrosine)IBA 05/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2018
1	CateninsIBA 09/2016
1	beta CateninIBA 09/2016
1	cyclic arginine-glycine-aspartic acid peptideIBA 06/2016
1	Transcription Factors (Transcription Factor)IBA 05/2014
1	nutlin 3IBA 08/2013
1	LuciferasesIBA 02/2012
1	Cell Adhesion MoleculesIBA 01/2012
1	DNA AdductsIBA 01/2009
1	Integrin beta1IBA 05/2008
1	StaurosporineIBA 12/2003
1	ThapsigarginIBA 12/2003

Therapy/Procedure

19	Therapeutics 05/2023 - 09/2010
5	Drug Therapy (Chemotherapy) 06/2021 - 09/2010
4	Radiotherapy 06/2021 - 01/2012
1	Lab-On-A-Chip Devices 11/2021
1	Adjuvant Radiotherapy 06/2021
1	Immunotherapy 04/2021
1	Adjuvant Chemotherapy 01/2012